tide (VIP) and the three monoamines norepinephrine (NE), histamine (HIS), and serotonin (5-hydroxytryptamine, 5-HT) in mouse cerebral cortical slices. We have observed that NE and HIS, but not 5-HT, act synergistically with VIP to increase CAMP levels. The rank-order of potency of several adrenergic agonists in potentiating the effect of VIP on CAMP levels is the following: epinephrine > NE > phenylephrine >> clonidine, with EC,,, of 2.2, 5, and 10 PM, respectively (clonidine being only marginally effective). This pharmacological profile is characteristic of the activation of a,-adrenergic receptors. This contention is substantiated by the observation that the potentiating effect of NE is antagonized by the selective n,-adrenergic antagonist prazosin at nanomolar concentrations.
The potentiating effect of HIS is mediated by H,-histaminergic receptors since it is antagonized by the selective HI-receptor antagonist mepyramine but not by cimetidine, a selective HZ-receptor antagonist. The synergistic interaction between VIP and NE is also observed in the presence of the adenosine antagonist theophylline, thus discarding the possibility of a mediation of the synergism by adenosine released by VIP. In view of the morphological and physiological properties of the VIP intracortical neuronal system and the noradrenergic projection to the cerebral cortex, it appears that sensory stimulation may constitute a behavioral event whereby the synergism between VIP and NE may become operative and lead to a drastic increase in the levels of CAMP within a discrete cortical volume delineated by the intersection of the tangentially organized noradrenergic fibers and a group of activated, radially oriented VIP intracortical neurons.
Vasoactive intestinal polypeptide (VIP) is a 28-amino acid polypeptide originally isolated from porcine duodenum by Said and Mutt (1970) . VIP-immunoreactive nerves have been visualized throughout the gastrointestinal (Costa et al., 1980) and genitourinary (Larsson et al., 1977) tracts, and in endocrine glands such as the pancreas (Larsson et al., 1978) and the thyroid gland (Ahren et al., 1980) . The presence of VIP has also been demonstrated in the PNS and CNS (Larsson et al., 1976; Loren et al., 1979) . In the CNS, VIP is highly concentrated in the cerebral cortex where it is localized to a homogeneous population of intracortical, bipolar neurons oriented perpendicularly to the pial surface and arborizing only minimally (50 to 120 wrn) in the horizontal plane, predominantly in layers I and IV-V (Loren et al., 1979; Morrison et al., 1984 recent quantitative immunohistochemical study in rat visual cortex has revealed that, on the average, there is one VIPimmunoreactive neuron per cortical column of 30.6 pm diameter and that such a cortical volume partially overlaps with similar adjacent columns determined by the arborization pattern of VIP-immunoreactive neurons (Morrison et al., 1984) . Thus, these morphological constraints restrict the cellular actions of VIP-containing neurons locally, to narrow and radially oriented transcortical volumes. The cellular actions of VIP in cerebral cortex include the stimulation of CAMP formation (Quick et al., 1978; Magistretti and Schorderet, 1984) and the activation of glycogenolysis (Magistretti et al., 1981) . Furthermore, VIP applied by iontophoresis has been shown to excite identified corticospinal neurons (Phillis et al., 1978) . Norepinephrine (NE) and serotonin (5-hydroxytryptamine, 5-HT) are two monoamines contained in highly divergent neuronal circuits which originate in small nuclei in the brainstem wherefrom they project to several regions of the CNS (Dahlstrom and Fuxe, 1964; Fuxe, 1965) . In the cerebral cortex the noradrenergic and serotonergic fibers are organized predominantly in a plane parallel to the pial surface spanning across several functionally distinct cortical regions (Morrison et al., 1978 (Morrison et al., , 1981 Lidov et al., 1980) ; therefore, in contrast to the VIP-containing intracortical neurons (Morrison  and Magis tretti, 1983) , NE-and 5-HT-containing fibers can influence their target cells throughout a vast rostrocaudal expanse of neocortex simultaneously.
Biochemical and lesion studies have revealed the existence of a third pontine monoaminergic projection which contains histamine (HIS) (Garbarg et al., 1974 (Garbarg et al., , 1976 Barbin et al., 1975) . Like VIP, the three monoamines can increase the levels of CAMP in neural tissues (for review, see Bloom, 1975; Daly, 1975; Greengard, 1976) and promote glycogenolysis in mouse cerebral cortical slices (Quach et al., 1978 (Quach et al., , 1980 (Quach et al., , 1982 .
This morphological and functional background induced us to investigate possible interactions between the VIPergic and monoaminergic cortical systems, since, although organized according to radically different morphological principles, they elicit, at least in part, identical cellular effects within the same region of the brain. The existence of such possible interactions has been substantiated by our recent observation that VIP and NE acted synergistically to increase CAMP levels in mouse cerebral cortical slices (Magistretti and Schorderet, 1984 
Materials and Methods
Swiss male albino mice (18 to 20 gm) were used throughout this study; they were maintained in an alternating 12.hr light/l2-hr dark cycle and had free access to food and water.
Cerebral cortical slices were prepared as follows (Magistretti et al., 1981) . Mice were decapitated and their brains rapidly removed. The cerebral cortex was then dissected on ice and immediately placed in a modified Krebs-Ringer bicarbonate buffer, pH 7.4 (KRG), containing (in millimolar concentration): NaCl, 120; KCl, 5; CaCl*, 2.6; MgSO,, 0.67; KH,PO,, 1.2; glucose, 3; NaHCOa, 27.5, previously gassed with 02:C02 (95:5). The dissected cortices (usually two per experiment) were then placed on a McIlwain tissue chopper, their ventral aspect facing the chopping plate, and 250-pm slices were prepared. The plate was then rotated by 90" and the cortices were cut again. Thus, the preparation used in the experiments consisted of cortical parallelepipeds of 250 Frn section and approximately 1 mm length (i.e., the cortical thickness).
The slices were then resuspended in ice-cold KRG (6 ml/ cortex) and incubated during 15 min at 37°C under continuous gassing (02:C02, 95:5) and vigorous shaking. The medium was then replaced and 260 ~1 of the slice suspension were distributed into individual polypropylene test tubes. After gassing with a stream of O,:CO, (95:5), the tubes were capped and incubated at 37°C. After 30 min, drugs (20 ~1) were added for 10 min. Antagonists were added 5 min prior to the agonists.
The tubes were then centrifuged, and the supernatant was removed and replaced with fresh KRG (300 ~1). The slice suspension was then sonicated for 5 set, boiled for 10 min, and centrifuged again. CAMP levels were determined as follows. Aliquots of the supernatants (10 to 100 ~1) were lyophilized and resuspended in 20 ~1 of Tris/EDTA (0.05 M/4 mM) buffer. CAMP was then determined with the saturation assay method described by Brown et al. (1971) . Experimental values were calculated by computer from a standard curve ranging from 0 to 16 pmol of CAMP. Proteins were determined in the pellets as described by Lowry et al. (1951 
Results
The synergism between VIP and NE in eliciting the accumulation of CAMP in mouse cerebral cortical slices is antagonized by a specific cu-adrenergic antagonist, phentolamine (Magistretti and Schorderet, 1984) . This observation indicates that NE, via the activation of a-adrenergic receptors, potentiates the stimulatory effects of VIP on CAMP levels. In order to define the nature of the a-adrenergic receptor subtype (cyl or cu2) mediating this effect, we have determined the rank-order potency of several adrenergic agonists. The concentrationresponse curves of epinephrine (EPI), NE and phenylephrine (PE) in potentiating the effect of 1 gM VIP on CAMP levels are shown in Figure 1 . The EC50 of the three adrenergic agonists are as follows: EPI, 2.2 wM, NE, 5 gM, and PE, 10 PM. It should be noted that, since EPI and NE per se stimulate CAMP formation via P-adrenergic receptors in mouse cerebral cortex (Schultz and Daly, 1973a; and Figure 1 legend) , the potentiating effect of the two catecholamines was determined in the presence of a specific P-adrenergic antagonist, dl-propranolol, at 100 FM. Therefore, the EC& values observed in these conditions reflect the affinity of EPI and NE for a-adrenergic receptors exclusively. As also shown in Figure 1 , the selective a,-adrenergic agonist clonidine at 100 ELM did not potentiate the effects of VIP on CAMP levels. This type of adrenergic agonist profile (Langer, 1974; Aghajanian and Rogawski, 1983) indicates that NE activates specific ai-adrenergic receptors to potentiate the increase in CAMP elicited by VIP. This contention is corroborated by the observation that the selective al-antagonist prazosin antagonizes in a concentration-dependent manner the potentiating effects of 10 FM NE (Fig. 2) . It is worth noting that a marked antagonism of the synergism between VIP and NE was observed already at nanomolar concentrations of prazosin (Fig. 2) .
We have also examined the effect of a fixed concentration of NE (10 PM) on the concentration-response curve of VIP in eliciting increases in CAMP. As shown in Figure 3 , a marked leftward shift of the concentration-response curve of VIP was observed in the presence of the catecholamine.
The potentiating effect of NE was assessed in the presence of the /3-adrenergic antagonist dl-propranolol at 100 PM, thus reflecting the activation of oc-adrenergic receptors exclusively.
A marked synergism in increasing CAMP levels between NE and adenosine has been reported previously by several authors (Sattin and Rall, 1970; Huang et al., 1971; Schultz and Daly, 1973b; Sattin et al., 1975) . We therefore had to consider the possibility that adenosine, released by VIP, could in fact mediate the synergism observed between NE and VIP. Therefore, we assessed the effects on CAMP levels of a combination of 1 PM VIP and 10 pM NE in the presence of the adenosine antagonist theophylline at 1 mM. As shown in Table I , the synergism between VIP and NE was fully expressed in the presence of theophylline.
It should be noted here that, when tested alone, the adenosine antagonist, even at a concentration of 10 mM, increased only marginally CAMP levels (picomoles per milligram of protein + SEM, n = 4; basal: 11.4 + 0.45; 10 mM theophylline: 24.8 + 1.15). The effects of HIS and 5-HT on CAMP increases elicited by VIP were subsequently examined. As shown in Figure 4 , HIS potentiated in a concentration-dependent manner the effect of 1 FM VIP in stimulating CAMP formation. The cellular actions of HIS are mediated in several cellular systems by two classes of histaminergic receptors, denominated H, and H, (Schwartz, 1979) . We therefore examined which class of receptor mediated the effects of HIS on the VIP-induced accumulations of CAMP, by using specific HIS receptor antagonists such as mepyramine (Hi-antagonist) and cimetidine (H2-antagonist). As shown in Figure 5 , a concentration-dependent antagonism by mepyramine of the potentiating effect of 100 FM HIS was observed, whereas cimetidine was inactive. These observations demon- (Fig. 5) . As shown in strate that the activation of specific HI-receptors by HIS mediates the synergistic interaction between HIS and VIP. It is interesting to note that the levels of CAMP observed in the presence of 1 FM VIP + 100 pM HIS + 0.5 or 1 PM mepyramine were lower than those observed in the presence of 1 ~.LM VIP Finally, in contrast to NE and HIS, 5-HT did not act synergistically with VIP to increase CAMP levels (Fig. 4) .
Discussion
In the present investigation we have examined the interactions, on the stimulation of CAMP formation, between VIP, a neuropeptide localized to an intracortical neuronal system, and NE, HIS, or 5-HT, three monoamines contained in long circuits projecting from the brainstem to the cerebral cortex. We have demonstrated that activation of Lul-adrenergic and H1-histaminergic receptors potentiates the increases in CAMP levels elicited by VIP in mouse cerebral cortex. No synergistic interaction in the formation of CAMP was observed between 5-HT and VIP.
NE has been demonstrated to promote the accumulation of CAMP in several rodent species (Bloom, 1975; Daly, 1975) . In rat cerebral cortex, both (Y-and fl-adrenergic receptors mediate et al., 1978, 1981 this action (Perkins and Moore, 1973; Schultz and Daly, 1973a) , whereas in mouse cerebral cortex a P-adrenergic mediation appears to predominate (Schultz and Daly, 1973a) . In contrast to NE, HIS and 5-HT per se increase only marginally CAMP levels in mouse cerebral cortex (Daly 1975; Fig. 4 legend) . It is interesting to note that in guinea pig hippocampal slices, HIS stimulates the formation of CAMP predominantly through HZ-receptors and this effect is positively modulated by the simultaneous occupation of HI-receptors (Schwartz, 1979) . Furthermore, in guinea pig cerebral cortical slices, HIS and NE display greater than additive effects in stimulating CAMP formation, and this synergism appears to be mediated by the concomitant activation of ol-adrenergic and H,-histaminergic receptors (Daly, 1975) . Sattin et al. (1975) have reported that the synergistic interaction between NE and adenosine in stimulating the formation of CAMP required the activation of a-adrenergic receptors by NE. Single-cell recordings from the lateral geniculate nucleus have shown that activation of a,-adrenergic receptors increases the efficacy of excitatory synaptic inputs rather than eliciting direct excitatory effects (Rogawski and Aghajanian, 1980a, b) . Thus, the results reported in this article, taken together with previous physiological and pharmacological studies of adrenergic and histaminergic receptors, suggest that activation of CNS al-adrenergic and H,-histaminergic receptors may lead to the facilitation of certain cellular effects of other neurotransmitters.
A functional dimension of the synergism between VIP and NE or HIS may be proposed by relating this interaction to the morphological characteristics of the neuronal systems that contain the peptide and the two monoamines in cerebral cortex. We will focus our attention more particularly on the interaction between VIP and NE since the noradrenergic coeruleocortical projection is best characterized.
Several considerations can be made. First, the existence of a functional synergism observed in vitro between VIP and NE on an intracellular event such as the increase in CAMP suggests that at least part of the target cells of VIPergic and noradrenergic neurons in cerebral cortex may be common to the two neurotransmitter systems. We have previously suggested that the concomitant activation of noradrenergic coeruleocortical cells and of a group of VIP-containing intracortical neurons would promote marked increases in the levels of CAMP within a discrete volume of the cerebral cortex (Magistretti and Schorderet, 1984) . The spatial coordinates of such a "cortical metabolic hot spot" would be delineated by the intersection of the tangentially organized noradrenergic fibers and a group of activated, radially oriented, bipolar VIP-containing neurons (Fig. 6) . Second, Madison and Nicoll (1982) have demonstrated that NE and CAMP, by blocking a Ca'+-activated K+ conductance, profoundly increase the responses of hippocampal pyramidal cells to depolarizing stimuli. This observation has recently been confirmed for NE by Gruol and Siggins (1984) . Thus, if similar CAMP-dependent intracellular mechanisms were to be operational within the neocortex, this would imply that the concomitant activation of the noradrenergic coeruleocortical projection and a group of VIP-containing intracortical neurons would lead to a sustained responsivity of neocortical pyramidal cells within a discrete cortical volume. The question then arises of when VIP-and NE-containing neuronal systems would be simultaneously active in cerebral cortex.
Electrophysiological recordings in behaving rats have demonstrated that NE-containing neurons exhibit pronounced responses to non-noxious, unexpected auditory, visual, and somatosensory stimuli (Aston-Jones and Bloom, 1981a, b) . The firing pattern and activatory inputs to VIP intracortical neurons are not known. However, at the light microscopic level, the overall morphological characteristics and pattern of dendritic arborization of VIP-immunoreactive neurons resemble those of the "bipolar cell" described in Golgi-impregnated material by Peters and Kimerer (1981) . These authors, by using a combined Golgi-electron microscopy technique, have demonstrated that in rat visual cortex "bipolar cells" receive direct thalamocortical inputs. These observations would therefore suggest that VIP-bipolar neurons could also be activated by sensory inputs relayed by specific thalamocortical afferents and, hence, that sensory stimulation could constitute a behavioral event whereby the synergistic interaction between VIP and NE would become operative within the terminal field of thalamocortical afferents in primary sensory cortex. The resolution at the cellular level of the synergism between VIP and NE cannot be achieved with the experimental paradigm used in this set of investigations. Recent evidence at the ultrastructural level indicates that VIP-immunoreactive cortical neurons preferentially synapse with the shafts of small diameter dendrites and that the synapses they form are predominantly symmetric (Peters and Connor, 1983) .
At present, however, the identity of the target cells where the synergistic interaction between VIP and NE (and HIS) is operational constitutes an open question. The observations reported in this article may provide a useful biochemical and pharmacological background for future electrophysiological and morphological studies aimed at the definition of the nature of the target cells of VIP-, NE-, and HIS-containing neurons within the cerebral cortex.
